1-1 of 1
Keywords: Apigenin-vorinostat-conjugate
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Clin Sci (Lond) (2021) 135 (14): 1751–1765.
Published: 27 July 2021
... alterations in AML have obtained only limited clinical efficiency without clear mechanism. Fortunately, we screened out a novel epigenetic agent named ApigeninVorinostat-Conjugate (AVC), which provides us a possibility to handle the heterogeneous malignancy. Its inhibition on HDACs was presented by HDACs...
Includes: Supplementary data